ArticleFrontiers in nutrition2025
Elastase inhibition by natural flavonoids: mechanistic insights and potential therapeutic applications.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Comparative Study of the Antioxidant Mediated Antiaging Properties of Endocarp Extracts FromFood science & nutrition · 2026Article
- Unveiling the Bioactive Potential of the Aerial Parts of BalkanPharmaceutics · 2026Article
- Article
- Targeting Skin Aging at Multiple Fronts: Integrated In Silico and In Vitro Evidence of Antioxidant, Anti-Protease, and UVB-Protective Effects ofInternational journal of molecular sciences · 2026Article
- Discovery of anti-inflammatory agents fromFrontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Overproduction of elastase plays an important role in the progression of inflammatory diseases. In this study, we compared the inhibitory effects of structurally similar bioactive flavonoids (quercetin, hyperoside, luteolin, and luteoloside) on elastase activity and elucidated their mechanisms of action. Enzyme inhibition assays and fluorescence, ultraviolet-visible (UV-vis), Fourier transform infrared (FT-IR), and circular dichroism (CD) spectroscopy examinations assessed the interactions among flavonoids, elastase, and elastase conformational changes. Molecular docking analyzed binding interactions. Thermodynamic parameters were calculated to determine the forces that stabilize the flavonoid-elastase complexes. Luteolin strongly inhibited elastase, followed by hyperoside, quercetin, and luteoloside. Fluorescence spectroscopy revealed static quenching of all flavonoids, with binding distances indicating non-radiative energy transfer between the flavonoids and elastase. Thermodynamic analysis revealed that hydrogen bonds and van der Waals forces primarily stabilized hyperoside and luteolin, whereas electrostatic interactions stabilized quercetin and luteoloside. UV-vis, FT-IR, and CD spectroscopy confirmed that flavonoids induced conformational changes in elastase, and increased random coil content was correlated with inhibitory strength. Molecular docking results supported these findings, with strong binding affinities between flavonoids and elastase, particularly luteolin and hyperosides. The four natural flavonoids inhibited elastase by altering their secondary structures. Modifications at positions 3 (C-ring) and 7 (A-ring) of flavonoids can enhance elastase inhibition. These findings provide a scientific basis for the development of flavonoid-based anti-inflammatory therapies targeting elastase-related diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.